Meeting of the Tick-Borne Disease Working Group, 30182-30183 [2018-13812]
Download as PDF
<![CDATA[
30182
Federal Register / Vol. 83, No. 124 / Wednesday, June 27, 2018 / Notices
• Creating a more efficient review
strategy for evaluating qualified health
claims on food labels.
• Discussing new or enhanced
labeling statements or claims that could
facilitate innovation to produce more
healthful foods and more healthful
consumer food choices.
• Modernizing the standards of
identity to provide more flexibility for
the development of healthier products,
while making sure consumers have
accurate information about these food
products.
• Providing opportunities to make
ingredient information more helpful to
consumers.
• FDA’s educational campaign for
consumers about the updated Nutrition
Facts Label.
We invite interested parties to provide
information on the above and other
topics related to the FDA Nutrition
Innovation Strategy.
III. Participating in the Public Meeting
Registration: To register for the public
meeting, please visit the following
website: https://www.fda.gov/Food/
NewsEvents/WorkshopsMeetings
Conferences/default.htm. Please provide
complete contact information for each
attendee, including name, title,
affiliation, address, email, and
telephone.
Registration is free and based on
space availability, with priority given to
early registrants. Persons interested in
attending this public meeting must
register by July 19, 2018, midnight
Eastern Time. Early registration is
recommended because seating is
limited; therefore, FDA may limit the
number of participants from each
organization. Registrants will receive
confirmation when they have been
accepted.
If you need special accommodations
due to a disability, please contact
Juanita Yates (see FOR FURTHER
INFORMATION CONTACT) no later than July
12, 2018.
Requests for Oral Presentations:
During online registration you may
indicate if you wish to present during a
public comment session or participate
in a specific session, and which topic(s)
you wish to address. We will do our
best to accommodate requests to make
public comments and requests to
participate in the focused sessions.
Individuals and organizations with
common interests are urged to
consolidate or coordinate their
presentations, and request time for a
joint presentation, or submit requests for
designated representatives to participate
in the focused sessions. All requests to
make oral presentations must be
received by July 12, 2018, midnight
Eastern Time. We will determine the
amount of time allotted to each
presenter and the approximate time
each oral presentation is to begin, and
will select and notify participants by
July 16, 2018. Speakers will be limited
to making oral remarks; there will not be
an opportunity to display materials such
as slide shows, videos, or other media
during the meeting. No commercial or
promotional material will be permitted
to be presented or distributed at the
public meeting.
Streaming Webcast of the Public
Meeting: This public meeting will also
be webcast. Webcast participants are
asked to preregister at https://
www.fda.gov/Food/NewsEvents/
WorkshopsMeetingsConferences/
default.htm.
Transcripts: Please be advised that as
soon as a transcript of the public
meeting is available, it will be accessible
at https://www.regulations.gov. It may
be viewed at the Dockets Management
Staff (see ADDRESSES). A link to the
transcript will also be available on the
internet at https://www.fda.gov/Food/
NewsEvents/WorkshopsMeetings
Conferences/default.htm.
Other Issues for Consideration: A
summary of key information on
participating in the meeting follows:
TABLE 1—INFORMATION ON PARTICIPATION IN THE MEETING
Date
Preregister
Electronic address
Request to make
an oral presentation
July 19, 2018: Closing date for registration.
https://www.fda.gov/
Food/
NewsEvents/
WorkshopsMeetingsConferences/
default.htm.
July 12, 2018 .........
Address
July 26, 2018 from
8:30 a.m. until
5:30 p.m. EDT.
Hilton Washington
DC/Rockville
Hotel, 1750
Rockville Pike,
Rockville, MD
20852.
Dated: June 22, 2018.
Leslie Kux,
Associate Commissioner for Policy.
seventh meeting of the Tick-Borne
Disease Working Group (Working
Group) on July 24, 2018, from 10:00 a.m.
to 4:00 p.m., Eastern Time. The seventh
meeting will be an on-line meeting held
via webcast. The Working Group will
review and vote on the content of the
five chapters that will be included in
the Working Group’s Report to
Congress.
[FR Doc. 2018–13831 Filed 6–26–18; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Tick-Borne Disease
Working Group
Office of HIV/AIDS and
Infectious Disease Policy, Office of the
Assistant Secretary for Health, Office of
the Secretary, Department of Health and
Human Services.
ACTION: Notice.
daltland on DSKBBV9HB2PROD with NOTICES
AGENCY:
The Department of Health and
Human Services (HHS) announces the
SUMMARY:
VerDate Sep<11>2014
16:58 Jun 26, 2018
Jkt 244001
The on-line meeting will be held
on July 24, 2018, from 10:00 a.m. to 4:00
p.m. Eastern Time.
DATES:
This will be an on-line
meeting that is held via webcast.
Members of the public may attend the
meeting via webcast. Instructions for
attending this virtual meeting will be
posted prior to the meeting at: https://
ADDRESSES:
PO 00000
Frm 00088
Fmt 4703
Sfmt 4703
Special
accommodations
Submit either electronic or
written comments
July 12, 2018: clos- Submit Comments to: https://
ing date to rewww.regulations.gov, or
quest special acDockets Management Staff
commodations
(HFA–305), Food and Drug
due to a disability.
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
www.hhs.gov/ash/advisory-committees/
tickbornedisease/meetings/.
FOR FURTHER INFORMATION CONTACT:
James Berger, Office of HIV/AIDS and
Infectious Disease Policy, Office of the
Assistant Secretary for Health,
Department of Health and Human
Services; via email at tickbornedisease@
hhs.gov or by phone at 202–795–7697.
SUPPLEMENTARY INFORMATION: The
Working Group invites public comment
on issues related to the Working Group’s
charge. Comments may be provided
over the phone during the meeting or in
writing. Persons who wish to provide
comments by phone should review
directions at https://www.hhs.gov/ash/
advisory-committees/tickbornedisease/
meetings/ before submitting a
request via email at tickbornedisease@
hhs.gov on or before July 19, 2018.
E:\FR\FM\27JNN1.SGM
27JNN1
Federal Register / Vol. 83, No. 124 / Wednesday, June 27, 2018 / Notices
Phone comments will be limited to
three minutes each to accommodate as
many speakers as possible. A total of 30
minutes will be allocated to public
comments. If more requests are received
than can be accommodated, speakers
will be randomly selected. The nature of
the comments will not be considered in
making this selection. Public comments
may also be provided in writing.
Individuals who would like to provide
written comment should review
directions at https://www.hhs.gov/ash/
advisory-committees/tickbornedisease/
meetings/ before sending
their comments to tickbornedisease@
hhs.gov on or before July 19, 2018.
During the meeting, the Working
Group will review and vote on the
content of the five draft chapters that
will be included in the Working Group’s
Report to Congress. Persons who wish to
receive the draft chapters should email
the tickbornedisease@hhs.gov and
request a copy. The chapters will be
available prior to the meeting.
Background and Authority: The TickBorne Disease Working Group was
established on August 10, 2017, in
accordance with section 2062 of the 21st
Century Cures Act, and the Federal
Advisory Committee Act, 5 U.S.C. App.,
as amended, to provide expertise and
review all HHS, DoD and VA efforts
related to tick-borne diseases to help
ensure interagency coordination and
minimize overlap, examine research
priorities, and identify and address
unmet needs. In addition, the Working
Group is required to submit a report to
the Secretary and Congress on their
findings and any recommendations for
improving the federal response to tickborne disease prevention, treatment and
research, and addressing gaps in those
areas.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
daltland on DSKBBV9HB2PROD with NOTICES
[FR Doc. 2018–13788 Filed 6–26–18; 8:45 am]
BILLING CODE 4140–01–P
National Eye Institute; Notice of Closed
Meeting
BILLING CODE 4150–28–P
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
Jkt 244001
Dated: June 21, 2018.
Michelle D. Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
National Institutes of Health
[FR Doc. 2018–13812 Filed 6–26–18; 8:45 am]
16:58 Jun 26, 2018
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Multiple Study Data
Coordinating Centers for Division of
Intramural Population Health Research
(DIPHR).
Date: July 30, 2018.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6710 B
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Sathasiva B. Kandasamy,
Ph.D., Scientific Review Administrator,
Division of Scientific Review. National
Institute of Child Health and Human
Development, 6710B Rockledge Drive,
Bethesda, MD 20892, (301) 435–6680,
skandasa@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: June 22, 2018.
James Berger,
Designated Federal Officer, Office of HIV/
AIDS and Infectious Disease Policy, TickBorne Disease Working Group.
VerDate Sep<11>2014
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
PO 00000
Frm 00089
Fmt 4703
Sfmt 4703
30183
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Eye Institute
Special Emphasis Panel; NEI Pathways To
Independence (K99) and Conference (R13)
Grant Applications.
Date: July 23–24, 2018.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5635
Fishers Lane, Bethesda, MD 20892.
Contact Person: Zhihong Shan, MD, Ph.D.,
Scientific Review Officer (Contractor),
Division of Extramural Activities, National
Eye Institute, National Institute of Health,
5635 Fishers Lane, Suite 1300, Bethesda, MD
20892, 301–435–1779, zhihong.shan@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.867, Vision Research,
National Institutes of Health, HHS)
Dated: June 22, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–13844 Filed 6–26–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary &
Integrative Health; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory
Council for Complementary and
Integrative Health.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council for Complementary and Integrative
Health.
Date: August 15, 2018.
Closed: 1:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Virtual
Meeting).
Contact Person: Partap Singh Khalsa,
Ph.D., DC, Director, Division of Extramural
Activities, National Center for
E:\FR\FM\27JNN1.SGM
27JNN1
]]>Agencies
[Federal Register Volume 83, Number 124 (Wednesday, June 27, 2018)]
[Notices]
[Pages 30182-30183]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-13812]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meeting of the Tick-Borne Disease Working Group
AGENCY: Office of HIV/AIDS and Infectious Disease Policy, Office of the
Assistant Secretary for Health, Office of the Secretary, Department of
Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Department of Health and Human Services (HHS) announces
the seventh meeting of the Tick-Borne Disease Working Group (Working
Group) on July 24, 2018, from 10:00 a.m. to 4:00 p.m., Eastern Time.
The seventh meeting will be an on-line meeting held via webcast. The
Working Group will review and vote on the content of the five chapters
that will be included in the Working Group's Report to Congress.
DATES: The on-line meeting will be held on July 24, 2018, from 10:00
a.m. to 4:00 p.m. Eastern Time.
ADDRESSES: This will be an on-line meeting that is held via webcast.
Members of the public may attend the meeting via webcast. Instructions
for attending this virtual meeting will be posted prior to the meeting
at: https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/.
FOR FURTHER INFORMATION CONTACT: James Berger, Office of HIV/AIDS and
Infectious Disease Policy, Office of the Assistant Secretary for
Health, Department of Health and Human Services; via email at
[email protected] or by phone at 202-795-7697.
SUPPLEMENTARY INFORMATION: The Working Group invites public comment on
issues related to the Working Group's charge. Comments may be provided
over the phone during the meeting or in writing. Persons who wish to
provide comments by phone should review directions at https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/ before submitting a request via email at
[email protected] on or before July 19, 2018.
[[Page 30183]]
Phone comments will be limited to three minutes each to accommodate as
many speakers as possible. A total of 30 minutes will be allocated to
public comments. If more requests are received than can be
accommodated, speakers will be randomly selected. The nature of the
comments will not be considered in making this selection. Public
comments may also be provided in writing. Individuals who would like to
provide written comment should review directions at https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/ before sending their comments to [email protected] on
or before July 19, 2018.
During the meeting, the Working Group will review and vote on the
content of the five draft chapters that will be included in the Working
Group's Report to Congress. Persons who wish to receive the draft
chapters should email the [email protected] and request a copy.
The chapters will be available prior to the meeting.
Background and Authority: The Tick-Borne Disease Working Group was
established on August 10, 2017, in accordance with section 2062 of the
21st Century Cures Act, and the Federal Advisory Committee Act, 5
U.S.C. App., as amended, to provide expertise and review all HHS, DoD
and VA efforts related to tick-borne diseases to help ensure
interagency coordination and minimize overlap, examine research
priorities, and identify and address unmet needs. In addition, the
Working Group is required to submit a report to the Secretary and
Congress on their findings and any recommendations for improving the
federal response to tick-borne disease prevention, treatment and
research, and addressing gaps in those areas.
Dated: June 22, 2018.
James Berger,
Designated Federal Officer, Office of HIV/AIDS and Infectious Disease
Policy, Tick-Borne Disease Working Group.
[FR Doc. 2018-13812 Filed 6-26-18; 8:45 am]
BILLING CODE 4150-28-P
